Chula Vista, CA, United States of America

Adrian Chrastina

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Adrian Chrastina

Introduction

Adrian Chrastina is a notable inventor based in Chula Vista, California. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of prostate cancer. With a total of 2 patents to his name, his work is paving the way for new therapeutic approaches.

Latest Patents

Chrastina's latest patents focus on compositions and methods for the treatment of prostate carcinoma. These patents disclose 1,4-naphthoquinone analogs and pharmaceutical compositions that include these analogs. The methods outlined aim to treat and ameliorate diseases associated with cancer, specifically prostate cancer. Additionally, the patents include combination therapies that involve a 1,4-naphthoquinone analog and a hormone therapy agent for subjects suffering from cancer.

Career Highlights

Adrian Chrastina is currently associated with Pellficure Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing effective treatments for serious health conditions.

Collaborations

Some of his notable coworkers include Per Borgström and Veronique Therese Baron, who contribute to the collaborative environment at Pellficure Pharmaceuticals, Inc.

Conclusion

Adrian Chrastina's innovative work in the pharmaceutical industry, particularly in cancer treatment, highlights his role as a significant inventor. His contributions are essential in advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…